Results 141 to 150 of about 42,888 (218)

Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial.

JAMA Oncol
Zhang M, Fu S, Feng J, Hong R, Wei G, Zhao H, Zhao M, Xu H, Cui J, Huang S, Wu X, Liu L, Sun J, Wu W, Zhu Y, He J, Zhao Y, Cai Z, Zheng W, Ye X, Shi J, Luo Y, Wang D, Chang AH, Hu Y, Huang H.   +25 more
europepmc   +1 more source

Case report: An intriguing case of Philadelphia chromosome-positive acute lymphoblastic leukemia recurrence. [PDF]

Front Oncol
Peccatori N, Chiocca E, Conter V, Tondo A, Marzorati M, Casini T, Veltroni M, Biondi A, Fazio G.   +8 more
europepmc   +1 more source

Early prediction of response in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib [PDF]

, 2003
Barbara Waßmann, Roman Pfeifer, Urban Scheuring, Anja Binckebanck, Nicola Gökbuget, Johannes Atta, Patrick T. Bruck, Harald Rieder, Claudia Schoch, Lothar Leimer, Rainer Schwerdtfeger, Gerhard Ehninger, Thomas Lipp, Jolanta B. Perz, Matthias Stelljes, Harald Gschaidmeier, Dieter Hoelzer, Oliver G. Ottmann   +17 more
openalex   +1 more source

Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e13a3 fusion transcripts in a patient with pre-existing essential thrombocythemia: a case report and literature review. [PDF]

Front Oncol
Wu Y, Cao D.
europepmc   +1 more source

A rare case of Acute Lymphocytic Leukemia (ALL) presenting with double Philadelphia chromosome: relapse or secondary leukemia? [PDF]

, 2003
Mireille Guimarães Vaz de Campos, Maria de Lourdes Chauffaille, Celso Arrais‐Rodrigues, Everson Augusto Krum, Mihoko Yamamoto   +4 more
openalex   +1 more source

MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications. [PDF]

Curr Hematol Malig Rep
Tran V, Salafian K, Michaels K, Jones C, Reed D, Keng M, El Chaer F.   +6 more
europepmc   +1 more source

Relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia responds well to a combination of modified hyper-CVAD, blinatumomab and tyrosine kinase inhibitor. [PDF]

EJHaem
Basile G, Galtier J, Cazaubiel T, Forcade E, Klein E, Bidet A, Botella-Garcia C, Mediavilla C, Clement L, Dumas PY, Pigneux A, Leguay T.   +11 more
europepmc   +1 more source

Philadelphia Chromosome-negative, bcr/abl-positive Chronic Myelogenous Leukemia.

, 2001
Koiti Inokuchi, Kazuo Dan
openalex   +2 more sources

PHILADELPHIA CHROMOSOME IN ACUTE LYMPHOCYTIC LEUKÆMIA

The Lancet, 1975
Biervliet, J.P. van, Hemel, J. van, Geurts, K., Punt, K., Boer-van Wering, E. de   +4 more
openaire   +3 more sources

Sensitivity to Tyrosine Kinase Inhibitors in a Human Philadelphia Chromosome-Positive (Ph+) Leukemia Model With the T315I-Inclusive Compound Mutation. [PDF]

Cureus
Nguyen TT, Tamai M, Harama D, Kagami K, Komatsu C, Kasai S, Akahane K, Goi K, Inukai T.   +8 more
europepmc   +1 more source